Thomas K Equels - 03 Mar 2022 Form 4 Insider Report for AIM ImmunoTech Inc. (AIMI)

Role
CEO & President, Director
Signature
Thomas K. Equels
Issuer symbol
AIMI
Transactions as of
03 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 09:06:58 UTC
Previous filing
13 Dec 2021
Next filing
26 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIM Options Award $0 +50,000 $0.000000 50,000 03 Mar 2022 Common Stock 50,000 $0.7000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.